Zevra Therapeutics IncNASDAQ:ZVRA
- LAST PRICE9.5850
- TODAY'S CHANGE (%)0.4550 (4.9836%)
- Bid / Lots9.5800/ 1
- Ask / Lots9.6200/ 1
- Open / Previous Close9.2400 / 9.1300
- Day Range
- 52 Week Range
- Volume678,506
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZVRA |
|---|---|---|
| 09:32 ET | 4438 | 9.25 |
| 09:33 ET | 12890 | 9.195 |
| 09:35 ET | 2066 | 9.24 |
| 09:37 ET | 200 | 9.18 |
| 09:39 ET | 387 | 9.27 |
| 09:42 ET | 200 | 9.26 |
| 09:44 ET | 3247 | 9.31 |
| 09:46 ET | 1698 | 9.2901 |
| 09:48 ET | 20790 | 9.355 |
| 09:50 ET | 27474 | 9.41 |
| 09:51 ET | 28749 | 9.52 |
| 09:53 ET | 24090 | 9.45 |
| 09:55 ET | 800 | 9.39 |
| 09:57 ET | 38538 | 9.4 |
| 10:00 ET | 2089 | 9.38 |
| 10:02 ET | 7185 | 9.29 |
| 10:06 ET | 300 | 9.33 |
| 10:08 ET | 597 | 9.3693 |
| 10:09 ET | 1200 | 9.44 |
| 10:11 ET | 800 | 9.35 |
| 10:18 ET | 555 | 9.39 |
| 10:20 ET | 1010 | 9.39 |
| 10:22 ET | 100 | 9.38 |
| 10:24 ET | 1226 | 9.34 |
| 10:26 ET | 541 | 9.37 |
| 10:27 ET | 650 | 9.34 |
| 10:29 ET | 490 | 9.32 |
| 10:31 ET | 2425 | 9.31 |
| 10:33 ET | 401 | 9.32 |
| 10:36 ET | 1865 | 9.305 |
| 10:38 ET | 100 | 9.29 |
| 10:44 ET | 200 | 9.31 |
| 10:45 ET | 953 | 9.32 |
| 10:47 ET | 1500 | 9.3139 |
| 10:51 ET | 200 | 9.32 |
| 10:54 ET | 150 | 9.325 |
| 10:58 ET | 1300 | 9.34 |
| 11:00 ET | 9920 | 9.35 |
| 11:02 ET | 200 | 9.3277 |
| 11:03 ET | 600 | 9.31 |
| 11:05 ET | 510 | 9.35 |
| 11:18 ET | 306 | 9.38 |
| 11:21 ET | 100 | 9.39 |
| 11:23 ET | 100 | 9.375 |
| 11:25 ET | 100 | 9.39 |
| 11:27 ET | 371 | 9.38 |
| 11:36 ET | 3945 | 9.37 |
| 11:38 ET | 232 | 9.38 |
| 11:39 ET | 100 | 9.39 |
| 11:43 ET | 100 | 9.37 |
| 11:50 ET | 320 | 9.3869 |
| 11:56 ET | 1469 | 9.37 |
| 11:57 ET | 100 | 9.38 |
| 11:59 ET | 400 | 9.38 |
| 12:01 ET | 100 | 9.36 |
| 12:03 ET | 2224 | 9.4 |
| 12:06 ET | 999 | 9.42 |
| 12:08 ET | 14954 | 9.45 |
| 12:12 ET | 300 | 9.46 |
| 12:14 ET | 1100 | 9.445 |
| 12:15 ET | 1100 | 9.46 |
| 12:17 ET | 595 | 9.47 |
| 12:19 ET | 3271 | 9.46 |
| 12:21 ET | 1199 | 9.4745 |
| 12:24 ET | 3637 | 9.45 |
| 12:26 ET | 1020 | 9.45 |
| 12:30 ET | 500 | 9.4437 |
| 12:32 ET | 2300 | 9.46 |
| 12:37 ET | 700 | 9.455 |
| 12:44 ET | 3400 | 9.4703 |
| 12:46 ET | 291 | 9.48 |
| 12:48 ET | 994 | 9.4805 |
| 12:50 ET | 28057 | 9.62 |
| 12:51 ET | 2925 | 9.59 |
| 12:53 ET | 527 | 9.58 |
| 12:55 ET | 9798 | 9.5787 |
| 12:57 ET | 29685 | 9.6 |
| 01:00 ET | 100 | 9.6177 |
| 01:02 ET | 2416 | 9.55 |
| 01:06 ET | 5854 | 9.5378 |
| 01:08 ET | 300 | 9.555 |
| 01:09 ET | 3804 | 9.53 |
| 01:11 ET | 950 | 9.54 |
| 01:13 ET | 462 | 9.549 |
| 01:15 ET | 1416 | 9.55 |
| 01:18 ET | 627 | 9.54 |
| 01:20 ET | 750 | 9.5432 |
| 01:22 ET | 300 | 9.53 |
| 01:24 ET | 1400 | 9.52 |
| 01:27 ET | 100 | 9.52 |
| 01:31 ET | 200 | 9.53 |
| 01:33 ET | 1936 | 9.5 |
| 01:36 ET | 456 | 9.49 |
| 01:38 ET | 200 | 9.51 |
| 01:42 ET | 100 | 9.51 |
| 01:44 ET | 700 | 9.51 |
| 01:45 ET | 1600 | 9.51 |
| 01:47 ET | 298 | 9.495 |
| 01:51 ET | 100 | 9.495 |
| 01:56 ET | 1794 | 9.52 |
| 01:58 ET | 883 | 9.54 |
| 02:00 ET | 300 | 9.54 |
| 02:02 ET | 2600 | 9.55 |
| 02:03 ET | 616 | 9.54 |
| 02:09 ET | 1742 | 9.56 |
| 02:12 ET | 1000 | 9.56 |
| 02:14 ET | 200 | 9.585 |
| 02:16 ET | 600 | 9.585 |
| 02:20 ET | 3004 | 9.565 |
| 02:21 ET | 3061 | 9.54 |
| 02:23 ET | 3201 | 9.57 |
| 02:25 ET | 1372 | 9.56 |
| 02:27 ET | 700 | 9.58 |
| 02:30 ET | 2316 | 9.56 |
| 02:32 ET | 700 | 9.57 |
| 02:34 ET | 1500 | 9.58 |
| 02:36 ET | 367 | 9.58 |
| 02:39 ET | 1200 | 9.585 |
| 02:41 ET | 1830 | 9.575 |
| 02:45 ET | 600 | 9.56 |
| 02:48 ET | 360 | 9.55 |
| 02:50 ET | 934 | 9.5401 |
| 02:54 ET | 1646 | 9.51 |
| 02:56 ET | 100 | 9.52 |
| 02:57 ET | 2000 | 9.52 |
| 02:59 ET | 785 | 9.5197 |
| 03:01 ET | 2250 | 9.51 |
| 03:03 ET | 1238 | 9.52 |
| 03:06 ET | 1668 | 9.52 |
| 03:10 ET | 904 | 9.505 |
| 03:12 ET | 200 | 9.51 |
| 03:14 ET | 200 | 9.51 |
| 03:15 ET | 214 | 9.52 |
| 03:17 ET | 150 | 9.53 |
| 03:19 ET | 1320 | 9.53 |
| 03:21 ET | 720 | 9.52 |
| 03:24 ET | 220 | 9.53 |
| 03:26 ET | 2759 | 9.53 |
| 03:28 ET | 1250 | 9.535 |
| 03:30 ET | 2163 | 9.533 |
| 03:32 ET | 3872 | 9.55 |
| 03:33 ET | 3420 | 9.54 |
| 03:35 ET | 1300 | 9.53 |
| 03:37 ET | 1200 | 9.55 |
| 03:39 ET | 3400 | 9.57 |
| 03:42 ET | 3142 | 9.58 |
| 03:44 ET | 19743 | 9.595 |
| 03:46 ET | 3873 | 9.61 |
| 03:48 ET | 8770 | 9.575 |
| 03:50 ET | 2200 | 9.58 |
| 03:51 ET | 8357 | 9.585 |
| 03:53 ET | 10413 | 9.565 |
| 03:55 ET | 15950 | 9.62 |
| 03:57 ET | 9048 | 9.615 |
| 04:00 ET | 73235 | 9.585 |
Nov 21, 2024
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA(TM) (arimoclomol) for Treatment of Niemann-Pick Disease Type C, from 4:51PM ET on Thursday Nov 21, 2024 by Dow Jones
4:51PM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 20, 2024
DJ Zevra Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 6:27AM ET on Wednesday Nov 20, 2024 by Dow Jones
6:27AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
DJ Zevra Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:27AM ET on Thursday Nov 14, 2024 by Dow Jones
11:27AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
*DJ Zevra Therapeutics 3Q Rev $3.7M >ZVRA, from 5:39PM ET on Tuesday Nov 12, 2024 by Dow Jones
5:39PM ET on Tuesday Nov 12, 2024 by Dow JonesZevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zevra Therapeutics Inc | 487.3M | -4.9x | --- |
Eton Pharmaceuticals Inc | 277.7M | -52.6x | --- |
CorMedix Inc | 626.8M | -12.4x | --- |
Elite Pharmaceuticals Inc | 659.9M | -106.0x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Scilex Holding Co | 105.8M | -0.4x | --- |
Company Information
Zevra Therapeutics, Inc. is a rare disease company science, data, and patients need to create transformational therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical stage pipeline and commercial stage assets. Its pipeline includes arimoclomol, an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate which is being developed as a treatment for idiopathic hypersomnia (IH), a rare neurological sleep disorder, and narcolepsy. Its commercial product, AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder (ADHD), in patients aged six years and older containing its prodrug, serdexmethylphenidate (SDX), and d-methylphenidate (d-MPH). Its other commercial product is OLPRUVA.
Contact Information
- Headquarters
- 1180 CELEBRATION BOULEVARD, SUITE 103CELEBRATION, FL, United States 34747
- Phone
- 321-939-3416
- Fax
- 319-665-2577
Executives
- Independent Chairman of the Board
- Tamara Favorito
- President, Chief Executive Officer, Director
- Neil Mcfarlane
- Chief Financial Officer, Treasurer, Secretary
- R. LaDuane Clifton
- Chief People Officer
- Alison Peters
- Executive Vice President - Business Development, Chief Commercial Officer
- Joshua Schafer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $511.6M |
|---|---|
Revenue (TTM) | $24.8M |
Shares Outstanding | 53.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.98 |
EPS | $-1.96 |
Book Value | $1.49 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 20.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -348.01% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
